Skip to main content

W. Robert Lee

Professor Emeritus of Radiation Oncology
Radiation Oncology
Box 3085 Med Ctr, Durham, NC 27710
201 Trent Drive, Box 3085, Durham, NC 27710

Overview


Prostate cancer, Intensity-modulated radiation therapy (IMRT), Image-guided radiation therapy (IGRT), Stereotactic Body Radiation Therapy (SBRT), Prostate HDR and LDR Brachytherapy, Quality of Life, Educational Technology

Current Appointments & Affiliations


Professor Emeritus of Radiation Oncology · 2025 - Present Radiation Oncology, Clinical Science Departments
Associate Professor of Urology · 2007 - Present Urology, Clinical Science Departments

In the News


Published April 5, 2016
Shorter, Intensive Radiation Can Be Recommended in Early Prostate Cancer

View All News

Recent Publications


Correlation of Biochemical Recurrence With Adverse Late Toxic Events Following Prostate Radiation Therapy (COBALT Study): An Individual Patient Data Meta-Analysis of 7 Randomized Trials.

Journal Article Int J Radiat Oncol Biol Phys · February 7, 2026 PURPOSE: The association between late toxicity and biochemical recurrence (BCR) after prostate radiation therapy is unclear. We set out to characterize the relationship between late gastrointestinal (GI) and genitourinary (GU) toxicity and BCR among patien ... Full text Open Access Link to item Cite

Updated 5-year results for short course abiraterone acetate and LHRH agonist for unfavorable intermediate and favorable high-risk prostate cancer.

Journal Article Prostate Cancer Prostatic Dis · June 2025 Combined androgen deprivation therapy (ADT) and radiotherapy (RT) improves outcomes for intermediate and high-risk prostate cancer. Treatment intensification with abiraterone acetate/prednisone (AAP) provides additional benefit for high-risk disease. We pr ... Full text Link to item Cite

Hypofractionated radiotherapy for prostate cancer (HYDRA): an individual patient data meta-analysis of randomised trials in the MARCAP consortium.

Journal Article Lancet Oncol · April 2025 BACKGROUND: Trials comparing moderately hypofractionated radiotherapy (MHFRT) to conventionally-fractionated radiotherapy (CFRT) for prostate cancer have varied considerably in intent (non-inferiority vs superiority) and MHFRT dose. We compare the efficacy ... Full text Link to item Cite
View All Publications

Recent Grants


A Prospective Comparative Study of Outcoems with Proton and Photon Radiation in Prostate Cancer PCS-2017C1-0422

ResearchPrincipal Investigator · Awarded by University of Florida · 2019 - 2027

Image-Guide Radiation Therapy of Prostate Cancer

ResearchInvestigator · Awarded by National Institutes of Health · 2006 - 2011

Digital tomosynthesis: a new paradigm for radiation treatment verification

ResearchCollaborator · Awarded by National Institutes of Health · 2007 - 2009

View All Grants

Education


Wake Forest University · 2000 M.S.
University of Virginia · 1989 M.D.